Laparoscopic vs. Robotic Ventral Hernia Repair With IPOM

Completed · Not applicable

Conditions studied: Ventral Hernia

In brief

The investigators aim to conduct a registry-based, randomized controlled trial to investigate if the robotic platform for minimally invasive ventral hernia repair with intraperitoneal onlay mesh (IPOM), when compared to the laparoscopic platform, will influence on early postoperative pain scores, wound morbidity (surgical site infections, surgical site occurrences and surgical site occurrences requiring procedural intervention), ventral hernia recurrence rate and abdominal wall-specific quality of life.

Key facts

Study ID

NCT03283982

Run by

The Cleveland Clinic

People needed

75

Starts

2017-09-11

Expected to finish

2021-01-31

Last updated by the study team

2022-07-25

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult patients (>18 years old)
• Primary or Incisional Ventral Hernia
• Midline defect location
• H. Width equal or less than 7 centimeters
• Elective setting
• Able to give informed consent
• Able to tolerate general anesthesia
• Considered eligible for minimally invasive ventral hernia repair
• Willing to undergo mesh-based repair
• Fascial closure is presumed to be achieved

You may not qualify if…

• Younger than 18 years old
• Non-midline hernia defects
• H. Width > 7cm
• Emergent setting ( acute incarceration or strangulation)
• Unable to give informed consent
• Unable to tolerate general anesthesia
• Considered not eligible for minimally invasive ventral hernia repair
• Not willing to undergo mesh based repair
• Fascial closure not intended or presumed not to be achieved

Where it is running

• Cleveland Clinic Comprehensive Hernia Center — Cleveland, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.